NCT00556413View on ClinicalTrials.gov

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2011

Study Completion Date

November 17, 2011

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (1)

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT00556413 - Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter